An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
Someone who’s been using the diabetes drug Mounjaro (tirzepatide) for years reported a worrying change: after two decades of manageable mild nausea the day after injection, they suddenly started vomiting for an hour or two about 24–48 hours after their shots for two weeks in a row. Before that, their blood sugar control (A1C) was excellent and they were on a steady 12.5 mg dose without problems. The note is a personal report, not a clinical trial or official side‑effect study. Mounjaro is the brand name for tirzepatide. It’s a man‑made medicine that acts like certain gut hormones that help control blood sugar and appetite. In plain terms, it tells the body to release insulin when food is around and slows how fast the stomach empties, which can reduce appetite. It’s used for type 2 diabetes and is also being looked at for weight loss, but it’s a strong drug and nausea is a known, common side effect. The information here comes from one person’s experience — an anecdote. It’s not a study and doesn’t tell us how common this new vomiting pattern is. Clinical trials and official side‑effect lists for tirzepatide do show nausea and vomiting can happen, especially when doses are changed or when someone starts treatment. But a sudden shift from mild nausea to repeated, prolonged vomiting after years on the same dose is something that deserves attention because it suggests side effects can emerge later, not only when treatment starts. Why this matters for regular people: if you or someone you know is on Mounjaro and thought side effects would only occur early on, this report is a reminder to stay alert. New or worsening symptoms—especially repeated vomiting—can affect hydration, nutrition, and how well the drug works for diabetes. Patients and caregivers should raise such changes with their prescribing clinician rather than assuming it’s “normal” or temporary. Caveats and risks: one anecdote alone doesn’t prove the drug caused the vomiting. Other causes (infections, other medications, alcohol, or an unrelated stomach issue) could be responsible. Still, tirzepatide is known to cause gastrointestinal side effects; serious or prolonged vomiting can require medical attention. People with a history of pancreatitis, severe stomach problems, or those unable to stay hydrated should be cautious and consult their doctor. Also, any change in symptoms after years on a steady dose should prompt a medical check‑in and possibly reevaluation of the dose or alternative treatments. Bottom line: this report is a useful warning to pay attention to new or worsening side effects on Mounjaro, but it’s one person’s experience and not definitive proof of a new drug risk. If you notice similar changes, contact your healthcare provider.
Source: r/Mounjaro